ISSN: 1859 - 2872
Baveno VII consensus (2021) on treatment of gastrointestinal bleeding due to portal hypertension
Main Article Content
Keywords
Abstract
Portal hypertension (PH) is a major consequence seen mainly in patients with cirrhosis, causing serious complications such as: Gastrointestinal bleeding (GI) due to rupture of esophageal and/or gastric veins, encephalopathy and ascites. Since 1990, the International Association for the study of portal hypertension has been established and named Baveno I (city of Italy). To date, there have been 7 consensus on the treatment of portal hypertension: Baveno I (1990), Baveno II (1995), Baveno III (2000), Baveno IV (2005), Baveno V (2010), Beveno VI (2015) and Baveno VII (2021). Since 2020, due to the COVID-19 pandemic, Baveno VII has been delayed and had to switch to an online form (virtual). This conference was also held in the city of Baveno (Italy) from October 27-30, 2021. The main contents of the Baveno VII consensus include: Methods of determining portal pressure, methods of diagnosing PH, advanced chronic liver disease, treatment of decompensated cirrhosis, treatment treatment of GI due to PH… In the framework of this article, we would like to detail the recommendations of Baveno VII for the treatment of GI due to PH.
Article Details
References
2. Franchis R, Bosch J, Garcia-Tsao G et al (2022) Baveno VII Renewing consensus in portal hypertension. Journal of Hepatology 2022, doi: https://doi.org/10.1016/j.jhep.2021.12.022.
3. Lo GH (2019) The use of Vasoconstrictors in acute variceal bleeding: How long is enough? Clinical Endoscopy 52: 36-39.
4. Sanchez-Jimenez B, Chavez-Tapia NC, Jakobsen JC et al (2018) Antibiotic prophylaxis for people with cirrhosis and variceal bleeding. Cochrane Database of Systematic Reviews 12: 013214. DOI: 10.1002/14651858.CD013214.
5. Traub J, Reiss L, AliwB et al (2021) Malnutrition in patients with liver cirrhosis. Nutrients 13: 540. https://doi.org/10.3390/nu13020540
6. Tsai CF, Chen MH, Wang YP et al (2017) Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study. Gastroenterology 152(1): 134-141.
7. Ibrahim M, El-Mikkawy A, Hamid MA et al (2019) Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: A randomised trial. Gut 68: 844-853.
8. García-Pagán JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Eng J Med 362: 2370-2379.
9. Rodrigues SG, Cárdenas A, Escosell A, Bosch J (2019) Balloon tamponade and esophageal stenting for esophageal variceal bleeding in cirrhosis: A systematic review and meta-analysis. Semin Liver Dis 39(02): 178-194.
10. Hudson M, Schuchmann M (2019) Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: A review of the evidence. European Journal of Gastroenterology & Hepatology 31: 434-450.
Article Sidebar
